Zeit Medical
Zeit Medical is developing a smart headband that continuously monitors a user's brain activity to detect neurological injuries like strokes. Leveraging AI and bioelectronics, the device aims to provide peace of mind to individuals at risk of stroke and enable timely medical intervention. The technology identifies specific patterns in EEG signals, similar to how arrhythmias are detected in EKGs, allowing for rapid diagnosis and treatment. The company's vision is to offer expert-level brain health monitoring in all settings, both in hospitals for continuous patient monitoring and annotation, and at home for patient peace of mind and faster access to treatment. Zeit Medical has received FDA breakthrough designation for its at-home stroke alert technology.
Zeit Medical
Zeit Medical is developing a smart headband that continuously monitors a user's brain activity to detect neurological injuries like strokes. Leveraging AI and bioelectronics, the device aims to provide peace of mind to individuals at risk of stroke and enable timely medical intervention. The technology identifies specific patterns in EEG signals, similar to how arrhythmias are detected in EKGs, allowing for rapid diagnosis and treatment. The company's vision is to offer expert-level brain health monitoring in all settings, both in hospitals for continuous patient monitoring and annotation, and at home for patient peace of mind and faster access to treatment. Zeit Medical has received FDA breakthrough designation for its at-home stroke alert technology.
TL;DR
Product: Wearable EEG headband + smartphone app and AI for at-home and hospital detection of stroke and seizures
Founded: 2019
Funding: $2.0M seed (Oct 2021)
Regulatory: FDA Breakthrough Device designation for at-home stroke alert technology
HQ: Redwood City, California, United States
Company Overview
Problem Domain
Early detection of neurological events (stroke, seizures) via continuous EEG monitoring in home and hospital settings.
Founded
2019
Industry
Biotechnology
Funding Track Record
$2,000,000
Announced Oct 28–29, 2021; round included participation from Y Combinator and multiple angel/VC investors.
Investor Signal
“Participated in Y Combinator S21; seed round included a syndicate of accelerators, VC funds and angel investors”